<?xml version="1.0" encoding="utf-8"?>
<publicwhip>

<spmotion spid="S1M-1718" date="2001-03-06" filename="day-bb-01_bb-03-06f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-06f.htm">
*S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-07" filename="day-bb-01_bb-03-07f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-07f.htm">
S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Linda Fabiani* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-09" filename="day-bb-01_bb-03-09f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-09f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Tommy Sheridan* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-12" filename="day-bb-01_bb-03-12f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-12f.htm">
 S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-13" filename="day-bb-01_bb-03-13f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-13f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Shona Robison* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-14" filename="day-bb-01_bb-03-14f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-14f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Ms Sandra White* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-16" filename="day-bb-01_bb-03-16f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-16f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Mr Gil Paterson*, Mr Lloyd Quinan*, Cathy Peattie* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-19" filename="day-bb-01_bb-03-19f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-19f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-20" filename="day-bb-01_bb-03-20f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-20f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Kay Ullrich* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-21" filename="day-bb-01_bb-03-21f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-21f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Donald Gorrie*, Mrs Margaret Ewing*, Andrew Wilson*, Elaine Smith* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-26" filename="day-bb-01_bb-03-26f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-26f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-27" filename="day-bb-01_bb-03-27f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-27f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Ms Margo MacDonald*, Mr Keith Raffan* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-03-29" filename="day-bb-01_bb-03-29f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-03-29f.htm">
 S1M-1718 Generic Drugs for Developing Countries (lodged on 5 March 2001) Tricia Marwick* 
</spmotion>

<spmotion spid="S1M-1718" date="2001-04-02" filename="day-bb-01_bb-04-02f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-04-02f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith, Ms Margo MacDonald, Mr Keith Raffan, Tricia Marwick 
</spmotion>

<spmotion spid="S1M-1718" date="2001-04-23" filename="day-bb-01_bb-04-23f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-04-23f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith, Ms Margo MacDonald, Mr Keith Raffan, Tricia Marwick 
</spmotion>

<spmotion spid="S1M-1718" date="2001-04-30" filename="day-bb-01_bb-04-30f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-04-30f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith, Ms Margo MacDonald, Mr Keith Raffan, Tricia Marwick 
</spmotion>

<spmotion spid="S1M-1718" date="2001-05-08" filename="day-bb-01_bb-05-08f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-05-08f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith, Ms Margo MacDonald, Mr Keith Raffan, Tricia Marwick 
</spmotion>

<spmotion spid="S1M-1718" date="2001-05-14" filename="day-bb-01_bb-05-14f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-05-14f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith, Ms Margo MacDonald, Mr Keith Raffan, Tricia Marwick 
</spmotion>

<spmotion spid="S1M-1718" date="2001-05-21" filename="day-bb-01_bb-05-21f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-05-21f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith, Ms Margo MacDonald, Mr Keith Raffan, Tricia Marwick 
</spmotion>

<spmotion spid="S1M-1718" date="2001-05-29" filename="day-bb-01_bb-05-29f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-01/bb-05-29f.htm">
S1M-1718 Robin Harper: Generic Drugs for Developing Countries—That the Parliament notes with concern the legal challenge which GlaxoSmithKline and other pharmaceutical companies have brought against the South African 1997 Medicines and Related Substances Control Amendment Act which was introduced by the South African Government, under the leadership of Nelson Mandela, to improve access to affordable medicines for the people of South Africa, and calls upon these companies to withdraw immediately from the legal action and undertake not to prevent governments of developing countries from adopting measures to make vital medicines more affordable. Supported by: Linda Fabiani, Tommy Sheridan, Shona Robison, Ms Sandra White, Mr Gil Paterson, Mr Lloyd Quinan, Cathy Peattie, Kay Ullrich, Donald Gorrie, Mrs Margaret Ewing, Andrew Wilson, Elaine Smith, Ms Margo MacDonald, Mr Keith Raffan, Tricia Marwick 
</spmotion>

</publicwhip>
